The extensive literature implicating inflammation in diabetes and many progressive neurodegenerative diseases, including AD, makes Stat4 a therapeutic target with immense potential for slowing, or even preventing, neurodegenerative disease progression. The gene discussed is STAT4; the disease is Alzheimer disease.